 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | PERKUMPULAN PERSAUDARAAN KORBAN NAPZA INDONESIA |
| Street 1: | Moch. Kafi 2 Street, Number 42 |
| Street 2: | N/A |
| City: | South Jakarta |
| Province: | DKI Jakarta |
| Post Code: | 12640 |
| Country: | Indonesia |
| Phone: | +6221 787 2453 |
| Organization Email: | nationalsecretariat.pkni@gmail.com |
| Web Site: | http://www.korbannapzaindonesia.org/ |
| Other Online Presence: | N/A |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | AHU-0001305.AH.01.08.TAHUN 2021 |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Community-Based Organization (CBO) |
| Organization Description: | |
| 1. our organizational focus is Greater recognition of the negative impacts of prohibition, increased protection of the human rights of people who use drugs, and fewer incidents of violence, stigma and discrimination against them. Better drug laws, policies and practices that are evidence-based and rights-based. Enhanced access of people who use drugs to quality, comprehensive, and affordable services and programmes, including for HIV, TB-HIV, Viral Hepatitis, and Harm Reduction. Greater meaningful involvement of people who use drugs in all areas of decision-making that affect their lives, and better outcomes for them health, equity, social inclusion, and wellbeing. Greater financial, political, and social resources and investments in the lives of and issues facing people who use drugs. 2. to promote the activities and impact of our key programs, and advocate to secure commitment from political leaders to step up action against TB. his has set the stage for governments to end TB by 2030 and the next UNHLM on TB expected in September 2023. But we need more champions to hold leaders accountable and ensure they keep their promises.Increase integration between TB, HIV and OST services. Deploy or develop opportunities for meaningful participation in the planning systems for HIV, TB and OST.(OPIATE SUBSTITUTION THERAPY). Advocate for an integrated service model and promote consumer satisfaction surveys as a means of gathering intelligence from consumer population. Advocates have places at table of key HIV, TB and OST planning forums. Advocates have points of influence on those engaged in policy forums. Address TB/HIV, MDR-TB and the needs of poor and vulnerable populations. This requires much greater action and input than DOTS implementation. Engage all care providers. TB patients seek care from a wide array of public, private, corporate and voluntary health-care providers. To be able to reach all patients, and ensure that they receive high-quality care, all types of health-care providers need to be engaged Empower bo |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Advocacy Civil Society and Community Engagement Delivery of health services and care Engaging political leaders and ensuring inclusive leadership Research and Development Technical Assistance Working on Community, Rights and Gender (CRG) Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 6 - 10 |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 1 - 5 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | PKNI members throughout Indonesia as well as health services, stakeholder partners, the TB community and professional organizations |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | Indonesia |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Contribute to health system strengthening based on primary health care. National TB control programmes must contribute to overall strategies to advance financing, planning, management, information and supply systems and innovative service delivery scale-up. To ensure that people who use drugs have fair and equitable access to the range of treatments promoted in global guidelines and based on availability within any given country.Advocate where people who inject drugs face barriers to TB or HIV treatment access. Advocate for access to OST (OPIATE SUBSTITUTION THERAPY) services as a core component of effective TB and HIV treatment. Advocate for reasonable access to medicines for OST (OPIATE SUBSTITUTION THERAPY), HIV and TB without political interference or barriers from pharmaceutical companies. Changes in clinical policy following advocacy intervention or interventions. Advocacy activities that bring attention to positive effects of OST (OPIATE SUBSTITUTION THERAPY) on health and wellbeing. |
|
Geographical Reach | |
| Which country is your headquarters located in: | Indonesia |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Indonesia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Involving PWUD communities In countries where successful approaches to integrating TB care into HIV prevention and treatment programming for PWUD have been tested, communities of PWUD have been involved in the decision-making process regarding the design, delivery and evaluation of the programming. The following interventions have been successful in utilizing the energy and involvement of PWUD communities in delivering TB care: • advocacy of take-home doses of OST that can be delivered to PWUD receiving TB treatment at home or in long-term in-patient TB facilities; • patient-supported TB treatment and ART at harm reduction sites and street-based outreach; • PWUD working alongside doctors to collect sputum samples in places where PWUD like to meet. These examples demonstrate that, in order to develop the most effective solutions to TB prevention, diagnosis, treatment delivery and care, and to achieve the desired results, PWUD/PWID communities must be involved. Drug-Resistant TB: Engage with HIV, TB, and drug control and prevention bodies at the local and national level in order to plan the best interventions and strategies to increase the access of PWUD/PWID to TB prevention, treatment and care TB-HIV: Document the impact of TB-HIV on communities of PWUD/PWID, including legal barriers, denial of care and lack of care integration; advocate for the elimination of legal barriers; Fundamental Research: The harm reduction model is client-centric and hinges on the principle of delivering services at the point of need, i.e., meeting PWUD/PWID where they are. While some PWUD may be open to the idea of substitution treatment through the period of TB treatment initiation, others may not. While some PWUD/PWID will attend peer group meetings and needle exchange programmes where they can also receive daily treatment for TB and/or HIV, others will not for a variety of reasons. Therefore, it is essential to develop interventions that will engage PWUD/PWID in a manner that is most effective. Global experience has shown that interventions that engage PWUD/PWID through street-based outreach or through community centres are the most effective in facilitating adherence to treatment. Other interventions that have involved providing small financial incentives and nutrition support have also proven successful Research: To support access to six-month treatment regimens for drug-resistant TB : - Reduce the price of Xpert MTB/XDR, which tests for resistance to isoniazid and fluoroquinolones, from $19.80 to $5 in accordance with the above-cited MSF analysis and provide full transparency of the COGS. - Replace 6-color modules and instruments with 10-color modules and instruments as part of routine service and maintenance at no additional charge. - Invest in the research and development of rapid molecular testing for resistance to bedaquiline and incorporate these resistance targets into a future version of the Xpert MTB/XDR cartridge. |
|
Declaration | |
| Declaration of interests: CONFLICT OF INTEREST STATEMENT LETTER CONFLICT OF INTEREST STATEMENT LETTER Perkumpulan Persaudaraan Korban Napza Indonesia The Indonesia Network of People Who Use Drugs To : STOP TB PARTNERSHIP We, Perkumpulan Persaudaraan Korban Napza Indonesia/Indonesia Network of People Who Use Drugs , here by declare that : 1.Our organizations not have a relationship with Stop TB Partnership its subsidiaries or associated organizations. Our organization has no relationship with the Stop TB Partnership or its associations. 2.Our organizations does not have a relationship with employee up to two (2) levels of the family line. 3.Our organizations will not offer, give or receive any kind of gifts to each employee Stop TB Partnership in related to any procurement activities Stop TB Partnership. 4.We declare that the above information is correct and for anyirregularities or incorrectness of the statement above, we will acceptany decision of Stop TB Partnership included but not limited to black listed from Stop TB Partnership procurement process in the future. Jakarta, 03 June 2023 Perkumpulan Persaudaraan Korban Napza Indonesia NATIONAL COORDINATOR MOCH ENDY MULIA PUTRA | |
| Application date: | June 3, 2023 |
| Last updated: | June 3, 2023 |